C2N Diagnostics’ Alzheimer’s test gets FDA breakthrough status

Beta-amyloid plaques and tau in the brain. Credit: NIH Image Gallery.



  • C2N Diagnostics’ Alzheimer’s test gets FDA breakthrough status